Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

Documenti analoghi

• Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children
  di: Avet-Loiseau, H, et al.
  Pubblicazione: (1999)
• Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations
  di: Boland, I, et al.
  Pubblicazione: (1999)
• No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan
  di: Calvet, L, et al.
  Pubblicazione: (2004)
• Primitive neuroectodermal tumor of the uterus
  di: Elizalde, C.R., et al.
  Pubblicazione: (2016)
• Primitive neuroectodermal kidney tumour.
  di: Khan, M. S., et al.
  Pubblicazione: (1995)